COVID-19 |
coronavirus disease 2019 |
SARS |
severe acute respiratory syndrome |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus-2 |
PHEIC |
public health emergency of international concern |
S-protein |
spike glycoprotein |
ACE2 |
angiotensin-converting enzyme 2 |
ACE |
angiotensin-converting enzyme |
RBD |
receptor-binding domain |
cryo-EM |
cryo-electron microscopy |
RAS |
renin-angiotensin system |
Ang I |
angiotensin I |
Ang II |
angiotensin II |
AT1 |
angiotensin receptor type 1 |
AT2 |
angiotensin receptor type 2 |
ACEIs |
ACE inhibitors |
ARBs |
AT1 receptor blockers |
ARDS |
acute respiratory distress syndrome |
ICU |
intensive care unit |
ADAM-17 |
ADAM metallopeptidase domain 17 |
TMPRSS2 |
Transmembrane Serine Protease 2 |
AR |
androgen receptor |
DHT |
dihydrotestosterone |
LNCaP |
activin-sensitive prostate cancer cells |
ER |
endoplasmic reticulum |
hESC |
human embryonic stem cell |
PD |
peptidase domain |
NAAE |
N-(2-aminoethyl)-1 aziridine-ethanamine |
IC50
|
the half maximal inhibitory concentration |
KD
|
the calculated affinity |
IFN |
interferon |
IL |
interleukin |
ERK |
extracellular signal-regulated kinase |
JNK |
c-Jun N-terminal kinase |
IPF |
idiopathic pulmonary fibrosis |
PAH |
pulmonary arterial hypertension |
ALI |
acute lung injury |
LPS |
lipopolysaccharide |
TLR4 |
toll-like receptor 4 |
MAP |
mitogen-activated protein |
ERK/MAPK |
extracellular-signal-regulated kinase/mitogen-activated protein kinase |
NF-κB |
nuclear factor-κB |
AMPA |
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid |
APJ |
the apelin receptor |
SIRT1 |
Sirtuin 1 |
AMPK |
AMP-activated protein kinase |
T2DM |
Type 2 diabetes mellitus |
ISG |
interferon stimulated gene |
fMLP |
N-formylmethionyl-leucyl-phenylalanine |
MAS1 |
the G protein-coupled receptor Mas |